South China Dental Show Highlight | Envista Group's ABT Business Unit Launches New MultiNeO® Implant in South China, Becoming a New Solution for "Double High" Patients' Implant Restoration

During the Dental South China International Expo 2026, Envista Group held a significant seminar titled "Clinical Breakthroughs and Safety Standards for Implant Restoration in 'Dual-High' Populations and New Technologies in Tertiary Oral Implantology." The event brought together top oral experts and scholars to focus on the clinical challenges of implant restoration for "dual-high" populations, jointly exploring directions for diagnostic and therapeutic breakthroughs and safety standards, thereby empowering the high-quality development of regional oral healthcare. The new-generation MultiNeO® Da Niu Dental Implant from Envista Group's ABT Business Unit, with its leading technological advantages and clinical adaptability, became the focal point of this grand event and received high recognition from industry experts.

This seminar featured a gathering of distinguished experts and was packed with substantial content. Multiple authoritative industry experts shared cutting-edge clinical achievements from various dimensions, establishing professional diagnostic and treatment standards and technical pathways for implant restoration in "dual-high" populations. It also provided authoritative guidance for the clinical application of suitable Dental Implants.

Professor Song Yingliang, School of Stomatology, Air Force Medical University

Professor Song Yingliang from the School of Stomatology at Air Force Medical University provided an in-depth analysis of the theory and technical system of occlusal reconstruction, explaining its crucial role in ensuring the long-term success of implant restoration for edentulous patients. Combined with successful long-term clinical follow-up data, this further solidified the theoretical foundation and clinical practice support for implant restoration in edentulous cases.

Professor Yang Zhaohui, Department of Stomatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Professor Yang Zhaohui from the Department of Stomatology at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, started from the underlying logic of surgical procedures, deconstructing strategies and key points for risk control in complex implant cases involving insufficient bone volume and anatomical variations, thereby clarifying clinical operation standards.

Dr. Liu Chenhan, Kiang Wu Hospital, Macau

Dr. Liu Chenhan from Kiang Wu Hospital in Macau, from the perspective of evidence-based medicine, interpreted the application advantages of the new TiUltra surface treatment technology in high-risk diabetic populations for implant treatment, further expanding the treatment boundaries for "dual-high" populations.

Dr. Liu Guohui, Medical Director, Guangzhou Shuguang Meiyun Dental Hospital

Dr. Liu Guohui, Medical Director of Guangzhou Shuguang Meiyun Dental Hospital, combined local clinical cases to share the optimization, upgrading, and standardized application of minimally invasive implant technology in "dual-high" populations, providing valuable localized experience for handling complex clinical cases.

Wang Qiang, Product Manager, ABT Business Unit, Envista Group

At the seminar, Wang Qiang, Product Manager of the ABT Business Unit at Envista Group, provided a detailed interpretation of the core technological innovations and clinical application advantages of the MultiNeO® Da Niu Dental Implant.

The 5th-generation patented nourishing Dental Implant – the German brand MultiNeO Oufa Da Niu® Dental Implant – integrates three core patented technologies:

• Innovative nourishing groove design, which enables nutrient transport and autogenous bone retention, aiding bone tissue repair;
• Patented immediate apex technology, achieving stable bone engagement without damaging bone, easily achieving immediate stability in extraction sockets;
• Paired with a stable 11-degree conical connection structure, effectively isolating oral bacteria.

It can precisely optimize blood supply and healing efficiency in the cortical bone region, scientifically increasing the contact area between the implant and bone tissue. This not only achieves ultra-high initial stability but also lays a solid foundation for the long-term stability of the implant, precisely meeting the core clinical needs of implant restoration for "dual-high" populations.

Left | Dr. Liu Guohui, Medical Director, Guangzhou Shuguang Meiyun Dental Hospital; Right | Stefan Nilsson, Global President of Nobel Biocare, Envista Group

The seminar witnessed a significant moment – Stefan Nilsson, Global President of Nobel Biocare at Envista Group, and Dr. Liu Guohui, Medical Director of Guangzhou Shuguang Meiyun Dental Hospital, jointly unveiled the plaque marking the landing cooperation for MultiNeO. This milestone initiative signifies the deep integration of Envista's internationally leading implant technology with high-quality local Chinese dental medical institutions. Envista will simultaneously provide dual product support with the Nobel TiUltra Implant featuring the new surface treatment and the new-generation MultiNeO® Da Niu Dental Implant, solidifying the technological and product foundation for precise and personalized implant treatment for "dual-high" populations.

As a major new implant product from Envista Group, the successful landing of the MultiNeO® Da Niu Dental Implant in South China represents a precise connection between international cutting-edge implant technology and the clinical needs of China's local "dual-high" population. It not only brings safer, more precise, and more efficient new diagnostic and therapeutic options for this special implant group but will also drive the continuous upgrading of domestic oral implant medical services towards refinement, specialization, and personalization, contributing to the high-quality development of the industry.

*Advertisement | This article is contributed by Envista. Relevant data and effects are subject to the official brand information.